Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease.

Published on Dec 18, 2018in Frontiers in Neurology2.889
· DOI :10.3389/FNEUR.2018.01081
Jens Burchard Schröder7
Estimated H-index: 7
,
Matthias Pawlowski12
Estimated H-index: 12
+ 5 AuthorsTobias Warnecke30
Estimated H-index: 30
Sources
Abstract
Background: Parkinson’s disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood (PB) of PD patients. Ten PD patients were diagnosed according to brain bank criteria and underwent detailed clinical examination, magnetic resonance imaging, PB and CSF immune cell profiling by multiparameter flow cytometry, and cytokine and chemokine measurements by bead-based arrays. Thirteen healthy elderly volunteers served as control population. Results: The proportions of activated T-lymphocytes and nonclassical monocytes in the CSF were increased in patients with PD compared to the control group. In accordance, we found increased levels of the pro-inflammatory cytokines IL-2, IL-6 and TNFα and of the monocyte chemoattractant protein 1 (MCP-1) in the CSF of the included PD patients. Conclusions: Our data provide novel evidence for a response of the innate and adaptive immune system in the central nervous system of patients with PD.
Figures & Tables
Download
📖 Papers frequently viewed together
630 Citations
201742.78Nature
24 Authors (David Sulzer, ..., Alessandro Sette)
278 Citations
1,055 Citations
References43
Newest
#1Sara Hall (Lund University)H-Index: 15
#2Shorena Janelidze (Lund University)H-Index: 33
Last. Oskar Hansson (Lund University)H-Index: 92
view all 6 authors...
Inflammation has been implicated in the pathogenesis of Parkinson’s disease (PD). We here investigate levels of inflammatory biomarkers in cerebrospinal fluid (CSF) in PD and atypical parkinsonian disorders (APD) compared with neurologically healthy controls. We included 131 patients with PD and 27 PD with dementia (PDD), 24 with multiple system atrophy (MSA), 14 with progressive supranuclear palsy (PSP) and 50 controls, all part of the Swedish BioFINDER study. CSF was analyzed for CRP, SAA, IL-...
38 CitationsSource
#1Matthias PawlowskiH-Index: 12
#2Gero LuegH-Index: 3
Last. Thomas DuningH-Index: 27
view all 9 authors...
Abstract Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood of patients with FTD. Thirty-two patients with behavioral variant frontotemporal dementia and 25 patients with primary progressive aphasia were included and compared to 14 healthy elderly controls. All pat...
2 CitationsSource
#1R. Lee Mosley (UNMC: University of Nebraska Medical Center)H-Index: 29
#2Howard E. Gendelman (UNMC: University of Nebraska Medical Center)H-Index: 113
14 CitationsSource
#1David Sulzer (Columbia University)H-Index: 92
#1David Sulzer (Columbia University)H-Index: 4
Last. Alessandro Sette (La Jolla Institute for Allergy and Immunology)H-Index: 163
view all 24 authors...
Epitopes derived from two regions of α-synuclein elicit immune responses in patients with Parkinson’s disease, involving IL-5-secreting CD4+ T cells, as well as IFNγ-secreting CD8+ cytotoxic T cells.
278 CitationsSource
#1Darcie Cook (Emory University)H-Index: 3
#2George T. Kannarkat (Emory University)H-Index: 11
Last. MariadeLourdes Tansey (Emory University)H-Index: 8
view all 11 authors...
Mutations associated with leucine-rich repeat kinase 2 are the most common known cause of Parkinson’s disease. The known expression of leucine-rich repeat kinase 2 in immune cells and its negative regulatory function of nuclear factor of activated T cells implicates leucine-rich repeat kinase 2 in the development of the inflammatory environment characteristic of Parkinson’s disease. The aim of this study was to determine the expression pattern of leucine-rich repeat kinase 2 in immune cell subse...
80 CitationsSource
#1Wassim Elyaman (Brigham and Women's Hospital)H-Index: 31
#2Samia J. Khoury (AUB: American University of Beirut)H-Index: 81
Interleukin (IL)-9 producing CD4+ T helper cells (Th9) are the newest addition to the T helper cell subsets. IL-9 binds to a heterodimeric receptor consisting of the IL-9 receptor (IL-9R) and a common γ chain also presents in IL-2, IL-4, IL-7, and IL-15 receptor complexes. In addition to Th9 cells, Th17 cells secrete smaller amounts of IL-9. Many functional and regulatory roles associated with Th9 cells are currently not fully understood. IL-9 is a pleiotropic cytokine that affects the activity ...
36 CitationsSource
Microglial activation is a key aspect of the neuroinflammatory process in neurodegenerative disorders including idiopathic and atypical parkinsonian disorders. With positron emission tomography (PET) it has become possible to image this phenomenon in vivo and over the last years patterns of microglia activation corresponding with the known distribution of neuropathological changes in these disorders have been demonstrated using this technique. In addition the effects of interventions aimed at su...
31 CitationsSource
#1Lisa Zondler (University of Ulm)H-Index: 10
#2Kathrin Muller (University of Ulm)H-Index: 19
Last. Jochen H. Weishaupt (University of Ulm)H-Index: 37
view all 22 authors...
Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disease affecting primarily the upper and lower motor neurons. A common feature of all ALS cases is a well-characterized neuroinflammatory reaction within the central nervous system (CNS). However, much less is known about the role of the peripheral immune system and its interplay with CNS resident immune cells in motor neuron degeneration. Here, we characterized peripheral monocytes in both temporal and spatial d...
59 CitationsSource
#1Ronald B. Postuma (MGH: Montreal General Hospital)H-Index: 74
#2Daniela Berg (German Center for Neurodegenerative Diseases)H-Index: 98
Last. G. Deuschl (CAU: University of Kiel)H-Index: 14
view all 18 authors...
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in clinical research but also may be used to guide clinical diagnosis. The benchmark for these criteria is expert clinical diagnosis; the criteria aim to systematize the diagnostic process, to make it reproducible across centers and applicable by clinicians with less expertise in PD diagnosis. Although motor abnormalities r...
1,640 CitationsSource
#1Brian K. Stansfield (Georgia Regents University)H-Index: 11
#2David A. Ingram (IU: Indiana University)H-Index: 14
Last. David A. Ingram (IU: Indiana University)H-Index: 47
view all 2 authors...
Monocytes are primitive hematopoietic cells that primarily arise from the bone marrow, circulate in the peripheral blood and give rise to differentiated macrophages. Over the past two decades, considerable attention to monocyte diversity and macrophage polarization has provided contextual clues into the role of myelomonocytic derivatives in human disease. Until recently, human monocytes were subdivided based on expression of the surface marker CD16. “Classical” monocytes express surface markers ...
98 CitationsSource
Cited By32
Newest
#1Nissen Sk (University of Tübingen)
#1Sara K. Nissen (AU: Aarhus University)H-Index: 9
Last. Marina Romero-RamosH-Index: 24
view all 7 authors...
BackgroundAlpha-synuclein aggregates and accumulation are associated with immune activation and neurodegeneration in Parkinsons disease. The immune activation is not only dependent on the brain-resident microglial cells but also involves peripheral immune cells, such as mononuclear phagocytes including monocytes and dendritic cells, found in the blood as well as infiltrated into the brain. Understanding the involvement of the peripheral immune component in Parkinsons disease is essential for the...
Source
#1Vidar Gundersen (Oslo University Hospital)
#1Vidar Gundersen (Oslo University Hospital)H-Index: 27
The reason why dopamine neurons die in Parkinson's disease remains largely unknown. Emerging evidence points to a role for brain inflammation in neurodegeneration. Essential questions are whether brain inflammation happens sufficiently early so that interfering with this process can be expected to slow down neuronal death and whether the contribution from inflammation is large enough so that anti-inflammatory agents can be expected to work. Here I discuss data from human PD studies indicating th...
Source
#1Christiane Pillny (University Hospital Bonn)
#2Louisa Nitsch (University Hospital Bonn)
Last. Ullrich Wüllner (German Center for Neurodegenerative Diseases)H-Index: 11
view all 5 authors...
Abstract We performed immune cell profiling by multiparameter flow cytometry in cerebrospinal fluid (CSF) and peripheral blood (PB) of Parkinson's Disease (PD) patients (n=9) and healthy controls (n=8). Classical and non-classical monocytes were increased in the CSF of PD patients.
Source
#1Tai Wang (Zhengzhou University)
#2Changhe Shi (Zhengzhou University)H-Index: 12
Last. Yuming Xu (Zhengzhou University)H-Index: 23
view all 10 authors...
Parkinson's disease (PD) is a heterogeneous neurodegenerative disease involving multiple etiologies and pathogenesis, in which neuroinflammation is a common factor. Both preclinical experiments and clinical studies provide evidence for the involvement of neuroinflammation in the pathophysiology of PD, although there are a number of key issues related to neuroinflammatory processes in PD that remain to be addressed. In this review, we highlight the relationship between the common pathological mec...
Source
#1Ashley S. Harms (UAB: University of Alabama at Birmingham)H-Index: 17
#2Sara A Ferreira (AU: Aarhus University)H-Index: 4
Last. Marina Romero-Ramos (AU: Aarhus University)H-Index: 24
view all 3 authors...
Parkinson's disease (PD) is a neurodegenerative disorder where alpha-synuclein plays a central role in the death and dysfunction of neurons, both, in central, as well as in the peripheral nervous system. Besides the neuronal events observed in patients, PD also includes a significant immune component. It is suggested that the PD-associated immune response will have consequences on neuronal health, thus opening immunomodulation as a potential therapeutic strategy in PD. The immune changes during ...
5 CitationsSource
#1Ana Borrajo (University of Rome Tor Vergata)H-Index: 8
#2Carlos Spuch (University of Vigo)H-Index: 23
Last. R. C. Agís-Balboa (University of Vigo)H-Index: 1
view all 5 authors...
The development of effective combined anti-retroviral therapy (cART) led to a significant reduction in the death rate associated with human immunodeficiency virus type 1 (HIV-1) infection. However,...
1 CitationsSource
After Alzheimer's disease, Parkinson's disease is the most frequent neurodegenerative disorder. Although numerous treatments have been developed to control the disease symptomatology, with some successes, an efficacious therapy affecting the causes of PD is still a goal to pursue. The genetic evidence and the identification of α-synuclein as the main component of intracellular Lewy bodies, the neuropathological hallmark of PD and related disorders, have changed the approach to these disorders. M...
Source
#1Jolene Su Yi Tan (NUS: National University of Singapore)
#2Yin Xia Chao (NUS: National University of Singapore)H-Index: 14
Last. Eng-King Tan (NUS: National University of Singapore)H-Index: 73
view all 4 authors...
The immune system has been increasingly recognized as a major contributor in the pathogenesis of Parkinson's disease (PD). The double-edged nature of the immune system poses a problem in harnessing immunomodulatory therapies to prevent and slow the progression of this debilitating disease. To tackle this conundrum, understanding the mechanisms underlying immune-mediated neuronal death will aid in the identification of neuroprotective strategies to preserve dopaminergic neurons. Specific innate a...
Source
#1Zulvikar Syambani Ulhaq (UM: State University of Malang)H-Index: 8
#2Cristian Peinado Garcia (Weston General Hospital)H-Index: 2
Strong evidence supports the involvement of inflammation processes in the development and progression of Parkinson’s disease (PD), where increasingly correlations have been identified between genetic variations in inflammation-related genes and PD. However, data varies between studies. Therefore, we conducted a meta-analysis to clarify associations between inflammation-related gene polymorphisms and PD risk. All studies were identified through online databases. Pooled and stratified groups based...
5 CitationsSource
#2Albert TorraH-Index: 3
Last. Jordi BovéH-Index: 22
view all 4 authors...
There is no consensus on the exact role of the adaptive immune system in Parkinson's disease pathogenesis, although there is increasing evidence that it is somehow involved. Moreover, T cell infiltration in the brain has not been thoroughly studied in Parkinson's disease and no study has assessed the infiltration in incidental Lewy body diseases cases that are considered to be early presymptomatic stages of the disease. In this study, we performed an immunohistochemistry/immunofluorescence quant...
4 CitationsSource